|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
SARS-CoV-2 RNA (COVID-19), Qualitative NAAT, (Self Collect)
Test Code39751
CPT Codes
87635<br><strong>Restricted Client Code</strong>
Preferred Specimen
One (1) anterior nares swab collected using the Quest Diagnostics COVID-19 Self Collection Kit
Minimum Volume
1 swab
Instructions
Order the SARS CoV2 RNA, QL NAAT, (Self Collect) test separately from other tests.
Transport using the provided FedEx shipper directly to Quest Diagnostics per instructions provided in the Quest Diagnostics COVID-19 Self Collection Kit.
Transport using the provided FedEx shipper directly to Quest Diagnostics per instructions provided in the Quest Diagnostics COVID-19 Self Collection Kit.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 14 days
Refrigerated: Acceptable
Frozen: Acceptable
Refrigerated: Acceptable
Frozen: Acceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Swab and media not provided to the customer in the Quest Diagnostics COVID-19 Self Collection Kit • Media tube without a swab inside
Methodology
Nucleic Acid Amplification Test (NAAT) includes RT-PCR or TMA
FDA Status
This test has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories.
Setup Schedule
Set up: Daily; Report available: 2-3 days
Reference Range
Not detected
Clinical Significance
The SARS-CoV-2 RNA (COVID-19), Nucleic-acid Amplification Test (NAAT) is a qualitative multi-target molecular diagnostics test that aids in the detection of COVID-19. This test is intended to be performed on respiratory specimens collected from individuals who meet the Centers for Diseases Control and Prevention (CDC) clinical and/or Epidemiological criteria for COVID-19 testing. For details visit: https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html.